Storys zum Thema Swiss

swissstaffing - Verband der Personaldienstleister der Schweiz

Temporary work explained

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Staff leasing employment driver creates 5,000 new jobs

ESCATEC

ESCATEC creates new innovative solutions for mutual growth with customers at new flagship HQ

Hermès

14

Hermès at the Salon International de la Haute Horlogerie (SIHH) 2018

Hombrechtikon Systems Engineering AG

HSE-AG introduces modular, automated qPCR TubeSealer / New bead-based technology integrates into any workflow and reduces contamination risk

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Staff leasing sector closes up by 4.2 percent in 3rd quarter

Eidgenössische Revisionsaufsichtsbehörde - RAB

FAOA concludes inspection regarding FIFA audit

Berne (ots) - The FAOA has inspected selected aspects regarding the audit of the annual financial statements and consolidated financial statements 2008 to 2014 of the Fédération Internationale de Football Association (FIFA). Numerous media reports provided clues to several suspected irregularities that might have happened in the FIFA entourage. It could not be excluded that these irregularities also had an impact on the ...

Neovii Pharmaceuticals AG

2

Neovii Pharmaceuticals AG announces new CEO

Zürcher Kantonalbank ZKB

Zürcher Kantonalbank grows profit by 7% to CHF 420 million in the first half of 2017

Zürich (ots) - Zürcher Kantonalbank significantly increased its net profit to CHF 420 million in the first half of 2017, a rise of 7% compared to the same period of 2016. All income drivers contributed to this pleasing result. With a total capital ratio of 17.9%, Zürcher Kantonalbank has further ...

Admeira

Bertrand Jungo appointed new CEO of Admeira

swissstaffing - Verband der Personaldienstleister der Schweiz

Impressive 6.9% growth in the staff leasing industry in the 2nd quarter

homegate AG

Jens Paul Berndt is the new Chief Technology Officer at Homegate AG

Zurich (ots) - Jens Paul Berndt (47), new Chief Technology Officer (CTO), is now consolidating the Homegate AG management team. Berndt assumes responsibility for technological development and operation of the leading Swiss real estate portal. He reports directly to CEO Axel Konjack. In the last 20 years, Jens Paul Berndt has become proficient in a broad range of areas in the digital and IT environment. Berndt previously ...

Debiopharm International SA

Debiopharm International SA and Arbor Pharmaceuticals, LLC Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)

Lausanne, Switzerland and Atlanta, GA (ots) - Triptodur (TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing for children with CPP Approval brings new CPP treatment formulation ...

Debiopharm International SA

GenePOC Announces an Exclusive Distribution Agreement with Cardinal Health covering the US market

Québec, Canada (ots) - GenePOC announces the signing of an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States. GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal ...

Berlinger Special AG

2

A new generation of anti-doping security bottles

Zürcher Kantonalbank ZKB

Zürcher Kantonalbank successfully launches Additional Tier 1 bond

Zurich (ots) - Zürcher Kantonalbank issues 2.125% Additional Tier 1 bond with a notional amount of CHF 750 million as of 30 June 2017. Zürcher Kantonalbank has issued today a new Additional Tier 1 (AT1) bond with contingent write-down with a notional amount of CHF 750 million and a coupon of 2.125%, meeting a strong investor demand. The new AT1 bond ...

Debiopharm International SA

Debiopharm International SA Announces Completion of Enrollment in Phase I/II Clinical Trial with Debio 1143 in SCCHN

Lausanne (ots) - A total of 96 patients randomized in France and Switzerland. Results expected in Q1 2019. Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the completion of enrollment in dose finding and ...

Debiopharm International SA

GenePOC announces FDA clearance for revogene(TM) instrument and its GBS LB test

Québec, Canada and Lausanne, Switzerland (ots) - GenePOC announces it received 510(k) clearance from the US Food and Drug Administration to market its first molecular assay to detect Group B Streptococcus and for the revogene molecular diagnostics instrument. GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is pleased to announce that it has received FDA ...

swissstaffing - Verband der Personaldienstleister der Schweiz

2

New industry barometer: staff leasing industry up 1.9% in 2016

Debiopharm International SA

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Lausanne, Switzerland and Waltham, Mass. (ots) - Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen's focus on strategic growth initiatives and generates near-term value Debiopharm International SA ...

Zürcher Kantonalbank ZKB

Zürcher Kantonalbank redeems Additional Tier 1 bond and plans to issue new Additional Tier 1 bond

Zurich (ots) - Zürcher Kantonalbank is calling the Additional Tier 1 bond with a notional amount of CHF 590 million as of 30 June 2017 and intends to issue a new Additional Tier 1 bond. Zürcher Kantonalbank is today announcing the redemption of its ...

Debiopharm International SA

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Basel, Switzerland, Lausanne, Switzerland and Helsinki, Finland (ots) - Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today ...

SYMETIS SA

2

Symetis and Boston Scientific reach USD 435 million purchase agreement

Debiopharm International SA

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...